Roundtable Discussions
In the second segment of this roundtable series, the panel discusses the importance of safe sampling in biomarker testing.
In the first segment of this roundtable series, the panel discusses the initial steps in NSCLC diagnosis and treatment.
Experts weigh in on the long-term results presented at the 2024 American Society of Clinical Oncology Annual Meeting.
The panel discusses key questions about NSCLC treatment regimens and the research that could answer them.
Experts discuss important management considerations and the importance of working with a multidisciplinary team.
A panel of experts shares their insights on key developments and advances in lung cancer treatment research.
An expert panel discusses treatment and quality-of-life considerations, as well as what to do while awaiting NGS results.
The panel discusses combination therapies and treatment considerations for patients without targetable mutations.
Experts weigh in on unmet needs and what clinicians should consider when treating patients who lack driver mutations.
Experts weigh in on NSCLC screening and diagnostic challenges and the prevalence of metastatic disease at diagnosis.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.